Open Label, Controlled, Post Marketing, Registry Study of Ribociclib (Ribo) Treatment Adherence and Patient Reported Outcomes in Participants Using ReX Technology Platform

NCT06344416 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Any Solid Oral Medication

Interventions

DEVICE: Use of ReX to dispense and monitor solid oral medication therapy.

Sponsor

Dosentrx Ltd.